Rasagiline for Parkinson’s Disease (Azilect)

Rasagiline, marketed as Azilect, is a monoamine oxidase type B (MAO-B) inhibitor used to treat idiopathic Parkinson’s disease. It can be prescribed as monotherapy in early stages or as adjunct therapy with levodopa in patients experiencing end-of-dose fluctuations, helping to manage symptoms like tremors, stiffness, and slow movement.

About rasagiline tablets

Rasagiline tablets, commonly known by the brand name Azilect, belong to a class of medications called MAO-B inhibitors. These drugs work by blocking the enzyme monoamine oxidase B, which normally breaks down dopamine—a neurotransmitter essential for controlling movement—in the brain. In Parkinson’s disease, dopamine-producing cells die off, leading to reduced dopamine levels and symptoms such as shaking (tremors), slow movement (bradykinesia), muscle rigidity, and postural instability. By preserving dopamine, rasagiline helps restore better motor control and coordination.

Parkinson’s disease is a progressive neurodegenerative disorder affecting millions worldwide. Early diagnosis and treatment can significantly improve quality of life. Rasagiline is available as oral tablets in 0.5 mg and 1 mg strengths, making it convenient for once-daily dosing. It is prescription-only and should only be used under medical supervision.

Key facts about rasagiline

• Brand name: Azilect (generic rasagiline also available).
• Dose: Typically 1 mg once daily for monotherapy; 0.5–1 mg with levodopa.
• Frequency: Once a day, with or without food.
• Starting dose: 1 mg for early Parkinson’s; lower if combined with levodopa.
• Available as: Tablets (0.5 mg, 1 mg).
• Age limit: Approved for adults; not routinely for children.
• Common side effects: Headache, joint pain, depression, flu-like symptoms.
• Prescription only: Yes, requires doctor’s assessment.

These facts make rasagiline a practical option for long-term management, with studies showing sustained benefits over 26 weeks or more.

About Parkinson’s disease

Parkinson’s disease (PD) is a chronic, progressive brain disorder primarily affecting movement. It occurs due to the loss of dopamine-producing neurons in the substantia nigra region of the brain. Symptoms develop gradually and worsen over time, including:

• Tremors, often starting in one hand.
• Bradykinesia (slowed movements).
• Muscle rigidity and stiffness.
• Postural instability, leading to balance issues.
• Non-motor symptoms like fatigue, depression, sleep disturbances, and cognitive changes.

In advanced stages, patients experience ‘off’ periods—times of immobility between levodopa doses—known as motor fluctuations. Rasagiline addresses both early motor symptoms and these later complications.

How rasagiline works and key studies

Rasagiline selectively inhibits MAO-B, preventing dopamine breakdown and elevating its levels in the striatum, the brain area controlling voluntary movement. This mechanism alleviates PD symptoms without significantly affecting other monoamines at therapeutic doses. It achieves near-complete (over 80%) MAO-B inhibition at 1 mg/day, with effects persisting for weeks after discontinuation due to slow enzyme recovery.

Clinical evidence from EMA-reviewed studies supports its efficacy:

• Early PD (monotherapy): In a 26-week study of 404 patients, 1 mg rasagiline reduced Unified Parkinson’s Disease Rating Scale (UPDRS) scores by 0.13 points (from 24.69 baseline) vs. a 4.07-point worsening with placebo.
• Advanced PD (adjunct to levodopa): Two studies (1,159 patients, 18–26 weeks) showed rasagiline reduced daily ‘off’ time compared to placebo or entacapone.

Additional benefits may include improvements in non-motor symptoms like depression and fatigue, though effects on cognition or smell are limited. Some research explores neuroprotective potential via binding to alpha-synuclein or GAPDH inhibition, but this remains investigational.

How and when to take rasagiline

Take rasagiline exactly as prescribed, usually 1 mg once daily. Swallow the tablet whole with water, with or without food. If combining with levodopa, start at 0.5 mg and titrate to 1 mg if tolerated. Do not crush or chew tablets. Missing a dose? Take it as soon as remembered unless near the next dose—do not double up. For best results, take at the same time daily.

Dosage for rasagiline

Doses above 1 mg/day are not recommended due to increased side effect risk without added benefit.

Getting the most from rasagiline tablets

• Continue levodopa as prescribed if using adjunctively.
• Monitor symptoms with a diary to track ‘on’/’off’ times.
• Maintain exercise, diet, and physiotherapy for optimal PD management.
• Attend regular check-ups for dose adjustments.
• Avoid abrupt stopping; taper if discontinuing to prevent symptom rebound.

Lifestyle integration enhances rasagiline’s effects, potentially delaying advanced symptoms.

Side effects of rasagiline tablets

Most side effects are mild and improve over time. Common ones (affecting >1 in 10 people) include headache and joint pain. Serious risks include serotonin syndrome (with certain drugs) or hallucinations.

Common side effects

• Headache
• Joint/muscle pain
• Depression or anxiety
• Flu-like symptoms
• Abdominal pain, nausea
• Dizziness or drowsiness

Serious side effects

Seek immediate medical help for:

• Signs of serotonin syndrome: agitation, fever, sweating, tremors.
• Melanoma risk (monitor skin changes; PD itself increases risk).
• High blood pressure (hypertensive crisis from tyramine-rich foods).
• Uncontrolled movements (dyskinesia) when with levodopa.

Report persistent issues to your doctor.

How to cope with side effects of rasagiline

• Headache: Rest, hydrate; paracetamol if approved.
• Joint pain: Gentle exercise, heat packs.
• Dizziness: Rise slowly; avoid alcohol.
• Nausea: Take with food.
• Never adjust dose without consulting your doctor.

Cautions of rasagiline tablets

Avoid if you have pheochromocytoma or severe liver issues. Use cautiously with heart disease, psychosis, or history of ulcers. Not for use with other MAOIs, pethidine, or certain antidepressants due to interaction risks.

Interactions with other medicines, alcohol, and more

Rasagiline has significant interactions:

• Prohibited: Other MAOIs (14-day gap), pethidine, sympathomimetics like ephedrine.
• Caution: SSRIs/SNRIs (serotonin syndrome risk), levodopa (dyskinesia), dextromethorphan.
• Food: Limit tyramine-rich foods (aged cheese, cured meats) at 1 mg dose to avoid hypertensive crisis.
• Alcohol: Limit; may worsen dizziness.

Inform your doctor of all medications.

Other medicines for Parkinson’s

• Levodopa (with/without carbidopa).
• MAO-B inhibitors: selegiline, safinamide.
• Dopamine agonists: pramipexole, ropinirole.
• COMT inhibitors: entacapone.
• Amantadine for dyskinesia.

Choice depends on disease stage and symptoms.

Pregnancy and breastfeeding with rasagiline

Not recommended during pregnancy or breastfeeding due to limited data. Discuss alternatives with your doctor.

Common questions about rasagiline

Is rasagiline a controlled drug?

No, it is not classified as controlled.

Can you drink alcohol with rasagiline?

Moderate alcohol is okay but avoid excess to prevent dizziness.

Is rasagiline available as a generic?

Yes, generic rasagiline tablets are available.

How long does rasagiline take to work?

Effects start within weeks; full benefits in 4–6 weeks.

Can rasagiline cause weight gain?

Not typically; some report appetite changes.

Frequently Asked Questions (FAQs)

How effective is rasagiline for Parkinson’s?

Highly effective in reducing ‘off’ time and improving UPDRS scores in trials.

What foods to avoid on rasagiline?

Tyramine-rich: aged cheeses, soy sauce, cured meats.

Can rasagiline be stopped suddenly?

No; taper to avoid withdrawal.

Does rasagiline slow Parkinson’s progression?

Symptomatic relief proven; neuroprotective effects unconfirmed.

Similar Articles

Alarming Rise in Self-Harm in Young People

Alarming Rise in Self-Harm in Young People

Skin Signs Of Non-Accidental Injury: Expert Guide For Clinicians

Lichen Simplex Of The Scrotum: Diagnosis And Treatment

Labial Adhesion In Prepubertal Girls: What Parents Need To Know

Thrush In Men: 5 Signs, Causes, And Treatment Options

Author

medha deb

 

Medha Deb is an editor with a master's degree in Applied Linguistics from the University of Hyderabad. She believes that her qualification has helped her develop a deep understanding of language and its application in various contexts.

Read full bio of medha deb